Literature DB >> 29883640

Prognostic Value of Tumor Length for Cause-Specific Death in Resectable Esophageal Cancer.

Xiangwei Zhang1, Yang Wang2, Pengfei Qu3, Jing Liu-Helmersson4, Linping Zhao5, Lin Zhang1, Shaowei Sang6.   

Abstract

BACKGROUND: The current esophageal cancer American Joint Committee on Cancer TNM staging system may not capture the full prognostic implications of the primary tumor. A study is needed to explore the prognostic value of tumor size on esophageal cancer-specific death.
METHODS: Patients who underwent surgical resection for non-metastatic esophageal cancer were selected from the Surveillance, Epidemiology and End Results Program database (United States, 1988 to 2014). With the use of statistics methods, maximally selected rank and two hazard models (Cox model and Fine-Gray model), the optimum cutoff point for tumor length in each T classification was estimated and the prognostic value of tumor size on esophageal cancer-specific death was analyzed.
RESULTS: A total of 4,447 patients were identified. The median tumor size was significantly correlated with T classification, with the correlation coefficient of 0.43 (p < 0.001). Patients in the T1 to T3 classifications who had larger tumor size showed a larger probability of cancer-specific death. The multivariate Cox model showed that tumor size was significantly associated with an increase in cancer-specific death in T1 (2.15, 95% confidence interval [CI]: 1.72 to 2.69) and T2 (1.31, 95% CI: 1.06 to 1.62) but was marginally significantly associated in T3 (1.12, 95% CI: 1.00 to 1.27) and insignificantly associated in T4 classification (p > 0.1). Similar results were found by using the multivariate Fine-Gray model.
CONCLUSIONS: We have found that combining T classification with tumor size can increase the precision in identifying the high-risk groups in T1 to T2 classifications. On the basis of esophageal cancer-specific death our study explores the prognostic cutoff point of tumor size by T classification.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29883640     DOI: 10.1016/j.athoracsur.2018.05.018

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  Comparative analysis of clinical, treatment, and survival characteristics of signet ring cell and adenocarcinoma of esophagus.

Authors:  Zhang Peng; Feng Li; Zeng Cheng; Wu Kai; Zhao Song
Journal:  J Gastrointest Oncol       Date:  2021-08

2.  Tumor Size as a Critical Prognostic Factor in T1-2 Stage Esophageal Cancer.

Authors:  Zilong Wu; Bentong Yu
Journal:  Gastroenterol Res Pract       Date:  2020-08-17       Impact factor: 2.260

3.  A Novel Model Combining Tumor Length, Tumor Thickness, TNM_Stage, Nutritional Index, and Inflammatory Index Might Be Superior to the 8th TNM Staging Criteria in Predicting the Prognosis of Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.

Authors:  Xiaohui Chen; Yilin Yu; Haishan Wu; Jianjian Qiu; Dongmei Ke; Yahua Wu; Mingqiang Lin; Tianxiu Liu; Qunhao Zheng; Hongying Zheng; Jun Yang; Zhiping Wang; Hui Li; Lingyun Liu; Qiwei Yao; Jiancheng Li; Wenfang Cheng
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

4.  The prognostic impact of tumor length in esophageal cancer: Protocol for a systematic review and meta-analysis.

Authors:  Xiangwei Zhang; Yang Wang; Yuanzhu Jiang; Zhaoyang Wang; Linping Zhao; Xianbiao Xue; Shaowei Sang; Lin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

5.  Prognostic value of tumor length and diameter for esophageal squamous cell cancer patients treated with definitive (chemo)radiotherapy: Potential indicators for nonsurgical T staging.

Authors:  Hongyao Xu; Shengxi Wu; Hesan Luo; Chuyun Chen; Lianxing Lin; Hecheng Huang; Renliang Xue
Journal:  Cancer Med       Date:  2019-09-04       Impact factor: 4.452

6.  The role of endoscopic tumor length in resected esophageal squamous cell carcinoma: a retrospective study.

Authors:  Peng Chen; Yuzhen Zheng; Hao He; Pei Yuan Wang; Feng Wang; Shuo Yan Liu
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

7.  A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis.

Authors:  Yang Li; Qingwu Du; Xiaoying Wei; Zhoubo Guo; Tongda Lei; Yanqi Li; Dong Han; Xiaoyue Wu; Kunning Zhang; Tian Zhang; Xi Chen; Jie Dong; Baozhong Zhang; Hui Wei; Wencheng Zhang; Qingsong Pang; Ping Wang
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

8.  Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.

Authors:  He-San Luo; Ying-Ying Chen; Wei-Zhen Huang; Sheng-Xi Wu; Shao-Fu Huang; Hong-Yao Xu; Ren-Liang Xue; Ze-Sen Du; Xu-Yuan Li; Lian-Xin Lin; He-Cheng Huang
Journal:  Radiat Oncol       Date:  2021-10-12       Impact factor: 3.481

9.  Competing risk nomogram to predict cancer-specific survival in esophageal cancer during the intensity-modulated radiation therapy era: A single institute analysis.

Authors:  Shengguang Zhao; Weixiang Qi; Jiayi Chen
Journal:  Oncol Lett       Date:  2020-03-06       Impact factor: 2.967

10.  Modeling the impact of delaying surgery for early esophageal cancer in the era of COVID-19.

Authors:  Maren E Shipe; Jordan J Baechle; Stephen A Deppen; Erin A Gillaspie; Eric L Grogan
Journal:  Surg Endosc       Date:  2020-11-02       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.